利妥昔单抗成功治疗IgG-4相关性硬化性疾病：一例新病例报告。
Successful treatment of IgG-4 related sclerosing disease with rituximab: a novel case report.
作者信息
Gillispie Miriah C, Thomas Richard D, Hennon Theresa R
机构信息
Department of Pediatrics, University of South Florida Morsani College of Medicine, Florida, USA.
The Women and Children's Hospital of Buffalo, NY, USA.
出版信息
Clin Exp Rheumatol. 2015 Jul-Aug;33(4):549-50. Epub 2015 Apr 16.
PMID:25897489
Abstract
IgG4-related sclerosing disease (IgG4-RSD) is a rare inflammatory disease that can affect multi organs. We describe a paediatric patient with ocular, nerve, and renal involvement successfully treated twice with corticosteroids and rituximab.
摘要
IgG4相关性硬化性疾病（IgG4-RSD）是一种可累及多器官的罕见炎症性疾病。我们描述了一名患有眼部、神经和肾脏受累的儿科患者，该患者先后两次成功接受了皮质类固醇和利妥昔单抗治疗。
Zotero 插件